Page last updated: 2024-11-11

s-farnesylcysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

S-farnesylcysteine: structural component of Saccharomyces cerevisiae mating hormone a-factor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

S-[(2E,6E)-farnesyl]-L-cysteine : An S-farnesyl-L-cysteine where the C=C double bonds at the 2- and 6-positions both have (E)-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6438372
CHEBI ID62197
MeSH IDM0161530

Synonyms (31)

Synonym
s-farnesylcysteine
(2r)-2-amino-3-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylpropanoic acid
s-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-l-cysteine
(2e,6e)-farnesyl-l-cysteine
CHEBI:62197
s-(2-trans,6-trans)-farnesyl-l-cysteine
s-trans,trans-farnesylcysteine
68000-92-0
trans,trans-farnesyl-l-cysteine
s-[(2e,6e)-farnesyl]-l-cysteine
trans-farnesyl-l-cysteine
s-(trans,trans)-farnesyl-l-cysteine
2-trans-6-trans-farnesylcysteine
s-(e,e)-farnesyl-l-cysteine
(e,e)-farnesyl-l-cysteine
(2r)-2-amino-3-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl}propanoic acid
s-trans-trans-farnesylcysteine
farnesylcysteine
C19691
59s52su9nv ,
unii-59s52su9nv
s-farnesyl cysteine
farnesyl cysteine
s-[(2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrienyl]-l-cysteine,(9ci)
s-[(2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]-l-cysteine
s-all-trans-farnesyl-l-cysteine
(e,e)-l-s-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-cysteine
Q27131636
SYSLNQMKLROGCL-BCYUYYMPSA-N
l-cysteine, s-((2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl)-
DTXSID501316758
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
S-polyprenyl-L-cysteine zwitterionAn L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of S-polyprenyl-L-cysteine; major species at pH 7.3.
S-farnesyl-L-cysteineAn S-polyprenyl-L-cysteine where the polyprenyl moiety is specified as farnesyl.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.06)18.7374
1990's22 (66.67)18.2507
2000's4 (12.12)29.6817
2010's5 (15.15)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.92 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index5.48 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]